NCT00449774View on ClinicalTrials.gov

Bioequivalence And Effect Of Food And Water On Lamotrigine in Healthy Volunteers

PHASE1CompletedINTERVENTIONAL
Enrollment

220

Participants

Timeline

Start Date

May 7, 2007

Primary Completion Date

June 19, 2007

Study Completion Date

June 19, 2007

Conditions
Mental Disorders
Interventions
DRUG

Lamotrigine IR tablets

Lamotrigine IR tablets will be available in dose strength of 200 mg.

DRUG

Lamotrigine ODT tablets

Lamotrigine ODT tablets will be available in dose strength of 200 mg.

Trial Locations (1)

75247

GSK Investigational Site, Dallas

Sponsors

Lead Sponsor

GlaxoSmithKline
All Listed Sponsors
lead

GlaxoSmithKline

INDUSTRY